Sebum Metabolomics and Lipidomics Clinical Trial, 200 Participants, Apr 24
Summary
A new clinical trial (NCT07549828) was registered on ClinicalTrials.gov studying sebum metabolomics and lipidomics for clinical applications. The trial will recruit 200 participants including healthy individuals and patients with skin conditions such as Acne, Atopic Dermatitis, Seborrheic Dermatitis, and Psoriasis. The study will use Sebutape sampling and a topical antibiotic ointment (Bacitracin/Polymyxin B/Neomycin) as interventions to investigate sebum composition and skin microbiome profiles.
“A total of 200 participants will be recruited, including healthy individuals, patients with skin diseases, individuals undergoing dermatological treatments or using skincare products, and a subset of healthy participants receiving short-term topical antibiotic intervention.”
About this source
ClinicalTrials.gov is the NIH-run registry of every clinical trial conducted in the United States, plus most international trials sponsored by US-based companies or institutions. By federal law, sponsors must register Phase 2 through Phase 4 studies before enrolling patients and post results within a year of completion. This feed tracks every new trial registration and study update, around 700 a month: drug interventions, device studies, behavioral protocols, observational research. Watch this if you scout drug candidates moving into mid or late-stage development, monitor competitor pipelines, or follow rare disease research where new trials signal patient hope. GovPing parses sponsor, phase, intervention, and target indication on each entry.
What changed
A new clinical trial registration (NCT07549828) was posted to ClinicalTrials.gov studying sebum metabolomics and lipidomics for clinical applications. The trial will recruit 200 participants including healthy individuals and patients with various skin diseases (Acne, Atopic Dermatitis, Seborrheic Dermatitis, Psoriasis). The study involves Sebutape sampling and topical antibiotic ointment interventions.
Clinical trial sponsors and investigators should ensure accurate registration on ClinicalTrials.gov. This is an informational record and does not impose compliance obligations on regulated entities beyond standard clinical research requirements.
Archived snapshot
Apr 25, 2026GovPing captured this document from the original source. If the source has since changed or been removed, this is the text as it existed at that time.
Sebum Metabolomics and Lipidomics for Clinical Applications
N/A NCT07549828 Kind: NA Apr 24, 2026
Abstract
This study aims to develop a standardized workflow for sebum sampling and metabolomics/lipidomics analysis using Sebutape. A total of 200 participants will be recruited, including healthy individuals, patients with skin diseases, individuals undergoing dermatological treatments or using skincare products, and a subset of healthy participants receiving short-term topical antibiotic intervention. The study will investigate sebum composition, skin microbiome profiles, and their interactions under different conditions to explore potential biomarkers and clinical applications.
Conditions: Acne, Atopic Dermatitis, Seborrheic Dermatitis, Psoriasis, Healthy Subjects (HS)
Interventions: Sebutape sampling, Bacitracin/Polymyxin B/Neomycin ointment (Yentuogin ointment)
Mentioned entities
Related changes
Get daily alerts for ClinicalTrials.gov Studies
Daily digest delivered to your inbox.
Free. Unsubscribe anytime.
Source
About this page
Every important government, regulator, and court update from around the world. One place. Real-time. Free. Our mission
Source document text, dates, docket IDs, and authority are extracted directly from NIH.
The summary, classification, recommended actions, deadlines, and penalty information are AI-generated from the original text and may contain errors. Always verify against the source document.
Classification
Who this affects
Taxonomy
Browse Categories
Get alerts for this source
We'll email you when ClinicalTrials.gov Studies publishes new changes.
Subscribed!
Optional. Filters your digest to exactly the updates that matter to you.